• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients.新型冠状病毒肺炎：近期一系列关于严重急性呼吸综合征冠状病毒2感染的免疫学、发病机制及过敏患者护理的重要临床与实验室报告。
Allergy. 2021 Mar;76(3):622-625. doi: 10.1111/all.14472.
2
2020: The year in review.2020年回顾
J Allergy Clin Immunol. 2021 Feb;147(2):495-497. doi: 10.1016/j.jaci.2020.12.632. Epub 2020 Dec 25.
3
The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.mRNA疫苗的世纪：新冠疫苗与过敏
J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):89-91. doi: 10.18176/jiaci.0665. Epub 2020 Jan 4.
4
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.COVID-19 大流行：关于组织过敏诊所的实用注意事项——一项 EAACI/ARIA 立场文件。
Allergy. 2021 Mar;76(3):648-676. doi: 10.1111/all.14453.
5
Allergen Immunotherapy in the Era of SARS-CoV-2.新冠病毒时代的变应原免疫疗法
J Investig Allergol Clin Immunol. 2020;30(6):459-461. doi: 10.18176/jiaci.0568. Epub 2020 May 11.
6
US public health resources for coronavirus disease 2019 that are relevant to allergy-immunology.美国针对2019冠状病毒病的、与过敏免疫相关的公共卫生资源。
Ann Allergy Asthma Immunol. 2021 Apr;126(4):316-318. doi: 10.1016/j.anai.2020.08.023. Epub 2020 Aug 25.
7
SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?SARS-CoV-2、COVID-19、皮肤与免疫学：目前我们了解多少？
Allergy. 2021 Mar;76(3):698-713. doi: 10.1111/all.14498. Epub 2020 Aug 12.
8
COVID-19 and allergy: How to take care of allergic patients during a pandemic?COVID-19 与过敏：大流行期间如何照顾过敏患者？
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26(Suppl 26):96-101. doi: 10.1111/pai.13367.
9
SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis.SARS-CoV-2 感染对老年人构成高风险：发病机制分析。
Arch Virol. 2021 Jun;166(6):1565-1574. doi: 10.1007/s00705-021-05042-w. Epub 2021 Mar 22.
10
Change in Allergy Practice during the COVID-19 Pandemic.COVID-19 大流行期间过敏实践的变化。
Int Arch Allergy Immunol. 2021;182(1):49-52. doi: 10.1159/000512079. Epub 2020 Oct 15.

引用本文的文献

1
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey.新冠疫情期间的过敏患者——临床实践考量：欧洲变态反应与临床免疫学会调查
Clin Transl Allergy. 2022 Jan 17;12(1):e12097. doi: 10.1002/clt2.12097. eCollection 2022 Jan.
2
Recent advances and developments in COVID-19 in the context of allergic diseases.新冠病毒肺炎在过敏性疾病背景下的最新进展与动态
Clin Transl Allergy. 2021 Sep;11(7):e12065. doi: 10.1002/clt2.12065.
3
COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI).2019冠状病毒病疫苗接种与变应原免疫疗法（AIT）——德国应用变态反应学会（AeDA）和德国变态反应与临床免疫学会（DGAKI）的立场文件
Allergol Select. 2021 Aug 24;5:251-259. doi: 10.5414/ALX02245E. eCollection 2021.
4
[Not Available].[无可用内容]。
Allergo J. 2021;30(5):24-33. doi: 10.1007/s15007-021-4846-1. Epub 2021 Aug 13.
5
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA).对合并抗体治疗（生物制剂）的过敏和2型炎症患者进行2019冠状病毒病疫苗接种——德国变态反应学与临床免疫学学会（DGAKI）和德国应用变态反应学学会（AeDA）的立场文件
Allergol Select. 2021 Apr 1;5:140-147. doi: 10.5414/ALX02241E. eCollection 2021.
6
COVID-19 pandemic and allergen immunotherapy-an EAACI survey.COVID-19 大流行与变应原免疫治疗：一项 EAACI 调查。
Allergy. 2021 Nov;76(11):3504-3516. doi: 10.1111/all.14793. Epub 2021 Aug 25.
7
Allergic reactions to COVID-19 vaccinations-unveiling the secret(s).新型冠状病毒肺炎疫苗的过敏反应——揭开奥秘
Allergy. 2021 Jun;76(6):1621-1623. doi: 10.1111/all.14734.

本文引用的文献

1
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper.COVID-19 大流行期间慢性鼻-鼻窦炎患者的管理。- EAACI 立场文件。
Allergy. 2021 Mar;76(3):677-688. doi: 10.1111/all.14629.
2
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020).ARIA-EAACI关于哮喘与2019冠状病毒病的声明（2020年6月2日）
Allergy. 2021 Mar;76(3):689-697. doi: 10.1111/all.14471. Epub 2020 Sep 21.
3
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).新型冠状病毒病的免疫学：机制、临床转归、诊断和展望——欧洲过敏与临床免疫学会（EAACI）的报告。
Allergy. 2020 Oct;75(10):2445-2476. doi: 10.1111/all.14462.
4
The role of peripheral blood eosinophil counts in COVID-19 patients.外周血嗜酸性粒细胞计数在 COVID-19 患者中的作用。
Allergy. 2021 Feb;76(2):471-482. doi: 10.1111/all.14465. Epub 2020 Jul 13.
5
A compendium answering 150 questions on COVID-19 and SARS-CoV-2.关于 COVID-19 和 SARS-CoV-2 的 150 个问题解答手册。
Allergy. 2020 Oct;75(10):2503-2541. doi: 10.1111/all.14449. Epub 2020 Jul 20.
6
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.COVID-19 大流行：关于组织过敏诊所的实用注意事项——一项 EAACI/ARIA 立场文件。
Allergy. 2021 Mar;76(3):648-676. doi: 10.1111/all.14453.
7
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.儿童 COVID-19 患者不同严重程度和过敏状态的 182 例临床特征。
Allergy. 2021 Feb;76(2):510-532. doi: 10.1111/all.14452. Epub 2020 Sep 3.
8
Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.新型冠状病毒病 19 中药物过敏反应的诊断和管理：EAACI 立场文件。
Allergy. 2020 Nov;75(11):2775-2793. doi: 10.1111/all.14439. Epub 2020 Jul 1.
9
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement.COVID-19 大流行时期变应性疾病患者使用生物制剂的相关考虑：一项 EAACI 立场声明。
Allergy. 2020 Nov;75(11):2764-2774. doi: 10.1111/all.14407.
10
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.在健康人群以及哮喘、COPD、肥胖、高血压和 COVID-19 危险因素患者的组织和免疫细胞中，ACE2、CD147、CD26 和其他 SARS-CoV-2 相关分子的分布。
Allergy. 2020 Nov;75(11):2829-2845. doi: 10.1111/all.14429. Epub 2020 Aug 24.

COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients.

作者信息

Pfaar Oliver, Torres Maria J, Akdis Cezmi A

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.

Allergy Clinical Unit, Hospital Regional Universitario de Málaga-UMA-ARADyAL, Málaga, Spain.

出版信息

Allergy. 2021 Mar;76(3):622-625. doi: 10.1111/all.14472.

DOI:10.1111/all.14472
PMID:32589296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361446/
Abstract
摘要